Wei Xiao

10.1k citations
433 papers · 7.9k indexed · 2 hit papers · h-index 44

Wei Xiao

410 papers receiving 7.8k citations

Hit Papers

Toll-like receptor 4 (TLR4) inhibitors: Cur...200201820262020202350100150200250

Peers

Wei Xiao
Comparison fields: 5 of 171
  • Complementary and alternative medicine 1.5k
  • Pharmacology 1.4k
  • Neurology 727
  • Biochemistry 363
  • Pharmacology 944
Replace Zhenzhong Wang with:
Zhenzhong Wang China
Boyang Yu China
Ling‐Yi Kong China
Yuping Tang China
Luyong Zhang China
Pengfei Tu China
Xiumei Gao China
Lixia Chen China
Zhong Zuo Hong Kong
Xiuping Chen China
Wei Xiao relative to Zhenzhong Wang China Zhenzhong Wang's profile →
Citations per field
00.5×1.6×
Zhenzhong Wang · 1×
Citations per year

Countries citing papers authored by Wei Xiao

Since Specialization
Citations

This map shows the geographic impact of Wei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xiao more than expected).

Fields of papers citing papers by Wei Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xiao. The network helps show where Wei Xiao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wei Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Xiao Line = papers co-authored together Wei Xiao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20250
3 20246
4 20243
5 20241
6 20239
7 20236
8 20238
9 202326
10 20235
11 20237
12 20214
13
Impaired Cognitive Abilities in Siblings of Patients with Temporal Lobe Epilepsy
20200
14 20206
15 202023
16 202011
17 201916
18 201744
19 201535
20 201448

About Wei Xiao

Wei Xiao is a scholar working on Complementary and alternative medicine, Pharmacology and Neurology, having authored 433 papers that have together received 7.9k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (57 papers), Natural product bioactivities and synthesis (50 papers), Pharmacological Effects of Natural Compounds (42 papers), Phytochemistry and Biological Activities (42 papers), Ginkgo biloba and Cashew Applications (42 papers), Neurological Disease Mechanisms and Treatments (38 papers), Computational Drug Discovery Methods (32 papers) and Ginseng Biological Effects and Applications (25 papers). The work is most often cited by research in Complementary and alternative medicine (1.5k citations), Pharmacology (1.4k citations) and Neurology (727 citations). Wei Xiao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhenzhong Wang, Gang Ding, Linguo Zhao, Liang Cao, Yonghua Wang, Wenzhe Huang, Jianjun Pei, Lin Ge, Zeyu Cao and Xianying Fang. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026